Meta Platforms, Inc.’s (NASDAQ: META) Instagram announced it would start collecting and measuring demographic information, including race and ethnicity, starting Thursday.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the Company's ongoing U.S. Phase 2/3 clinical trial to evaluate the safety and efficacy of Tempol as a treatment for COVID-19. The
Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™
AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally